About KLOTHO Therapeutics
KLOTHO Therapeutics is a company based in San Diego (United States) founded in 2016.. KLOTHO Therapeutics has raised $10 million across 1 funding round from investors including Thynk Capital. KLOTHO Therapeutics offers products and services including Human Klotho Protein. KLOTHO Therapeutics operates in a competitive market with competitors including Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Nov 02, 2017
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KLOTHO Therapeutics
KLOTHO Therapeutics offers a comprehensive portfolio of products and services, including Human Klotho Protein. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Patented protein that delays aging-related diseases like cognitive decline.
Funding Insights of KLOTHO Therapeutics
KLOTHO Therapeutics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $10.0M
-
First Round
First Round
(02 Nov 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Series A - KLOTHO Therapeutics | Valuation | Thynk Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in KLOTHO Therapeutics
KLOTHO Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Thynk Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech & life sciences focused VC firm funding companies in South Africa
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by KLOTHO Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - KLOTHO Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Klotho Therapeutics Comparisons
Competitors of KLOTHO Therapeutics
KLOTHO Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
UBaaS platform for plant-based recombinant protein bioproduction is offered.
|
|
| domain | founded_year | HQ Location |
Animal-free growth factors are developed for life science applications.
|
|
| domain | founded_year | HQ Location |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| domain | founded_year | HQ Location |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
|
| domain | founded_year | HQ Location |
Biopharmaceuticals and proteins are developed using green plants as hosts.
|
|
| domain | founded_year | HQ Location |
Developer of recombinant biologics for animal and human health
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about KLOTHO Therapeutics
When was KLOTHO Therapeutics founded?
KLOTHO Therapeutics was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is KLOTHO Therapeutics located?
KLOTHO Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is KLOTHO Therapeutics a funded company?
KLOTHO Therapeutics is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Nov 02, 2017.
What does KLOTHO Therapeutics do?
Klotho Therapeutics was founded in 2016 in San Diego, United States, within the biotechnology sector. Technology mimicking the human Klotho protein, a single-pass membrane protein, is developed to address aging-related conditions. Longevity is promoted, while onset of dementia, kidney disease, diabetes, and cancer is delayed through this approach. Operations focus on patent-pending innovations for therapeutic applications.
Who are the top competitors of KLOTHO Therapeutics?
KLOTHO Therapeutics's top competitors include Future Fields, Qkine and Oxford Expression Technologies.
What products or services does KLOTHO Therapeutics offer?
KLOTHO Therapeutics offers Human Klotho Protein.
Who are KLOTHO Therapeutics's investors?
KLOTHO Therapeutics has 1 investor. Key investors include Thynk Capital.